Causes of portal venous thrombosis in cirrhotic patients: The role of genetic and acquired factors

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 7, 2005, Pages 745-751

  Mangia, A ^a   Villani, M R ^a   Cappucci, G ^a   Santoro, R ^a   Ricciardi, R ^a   Facciorusso, D ^a   Leandro, G ^b   Caruso, N ^a   Andriulli, A ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Liver cirrhosis; Portal vein thrombosis; Prothrombotic disorders

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; HOMOZYGOSITY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RISK FACTOR; SCLEROTHERAPY; THROMBOCYTE COUNT; THROMBOPHILIA; VARICOSIS;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; ESOPHAGEAL AND GASTRIC VARICES; FACTOR V; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOMOZYGOTE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN; SCLEROTHERAPY; VENOUS THROMBOSIS;

EID: 21244479368     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200507000-00009     Document Type: Article

References (23)

1. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-1231.
2. Shafer AI. Hypercoagulable states: molecular genetics in clinical practice. Lancet 1994; 344:1739-1742.
3. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
4. Denninger MH, Beldjord K, Durand F, Denie C, Valla D, Guillin MC. Budd Chiari syndrome and factor V Leiden mutation. Lancet 1995; 345:525-526.
5. Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J Intern Med 1997; 740 (Suppl.):9-15.
6. Mahmoud AEA, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40:798-800.
7. Chamouard P, Pencreach E, Maloisel F, et al. Frequent factor II G20210 mutation in idiopathic portal vein thrombosis. Gastroenterology 1999; 116:144-148.
8. Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 2000; 46:534-539.
9. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-591.
10. Valla DC, Condat B. Portal vein thrombosis: pathophysiology, pathogenesis, and management. J Hepatol 2000; 32:865-871.
11. AISF practice guidelines for portal hypertension. Ital J Gastroenterol Hepatol 1999; 31:224-234.
12. Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J Intern Med 1997; 740 (Suppl.):9-15.
13. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997; 34:171-187.
14. Amitrano L, Brancaccio V, Guardascione AM, Margaglione M, Iannaccone L, D'Andrea G, et al. Inherited coagulation disorders in cirrhotic patients with portal hypertension. Hepatology 2000; 31:345-348.
15. The North Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 319:983-989.
16. Margaglione M, D'Andrea G, Cappucci G, Grandone E, Giuliani N, Colaizzo D, et al. Detection of factor V Leiden mutation using SSCP. Thromb Haemost 1996; 76:814-815.
17. Bertina M. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997; 43:1678-1683.
18. De Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, de Stefano V, et al. Elevated total plasma homocysteine and C → T mutation of the 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 1996; 59:262-264.
19. Mangia A, Vallari D, Di Bisceglie AM. Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol 1994; 43:125-128.
20. Mangia A, Margaglione M, Cascavilla I, Gentile R, Cappucci G, Facciorusso D, et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 1999; 94:2983-2987.
21. Gervais A, Czernichow B, Grunebaum L, Wiesel ML, Auperin A, Rivalland D, et al. Serum cardiolipin antibodies in patients with alcohol cirrhosis [in French]. Gastroenterol Clin Biol 1996; 20: 736-742.
22. Politoske D, Rails P, Korula J. Portal vein thrombosis following endoscopic variceal sclerotherapy: prospective controlled comparison in patients with cirrhosis. Dig Dis Sci 1996; 41:185-190.
23. Yerdel MA, Gunson B, Mirza D, Karayalcin K, Olliff S, Buckels J, et al. Portal vein thrombosis in adults undergoing liver transplantation. Transplantation 2000; 69:1873-1881.